FEBRUARY - 2023LIFE SCIENCES REVIEW6The human eye is prone to an optical illusion, and hence the manual ways of checking cell morphology through cell culture microscopes lead to inefficiencies. Automated and AI-driven cell culture solutions are now dominating the sector to measure cell culture health based on consistent parameters.3D cell culture is another cutting-edge technology transforming the sector. Significant growth in the biopharmaceutical industry is driving unexpected innovation and demand for cell culture products for drug discovery and safety testing. Although 2D cell cultures have been used in labs since the 1950s, the market for 3D cultures, which more precisely simulate human tissue in vivo without using animal test subjects, is dramatically pushing the horizon for accelerating drug discovery. Driven by these developments, the 3D cell culture market is expected to surpass a valuation of $ 55.93 billion by 2030, at a CAGR of 11.5 percent.To put the spotlight on other key developments, Life Sciences Review Europe illustrates how the cell culture sector is significantly advancing with the latest innovations. This edition also features thought leadership articles from Gil Carrasquinho, VP Head of Cell Therapy, Santen, and Anders Damholt, Head of Clinical Development, Human Health Innovation, Chr. Hansen. They shed light on innovative probiotics empowering microbiomes and 3D bioprinting.In this edition of Life Sciences Review Europe, we also bring to you the story of some of the top cell culture solution providers in Europe. In the list, SABEU particularly stands out for providing exceptional cell culture inserts and well plates. The company is championing in the production of membranes and plastic components for medical and life sciences applications powered by a state-of-the-art track-etched membrane technology.Through the following pages, we aim to shine a light on the innovative trends and latest developments in the cell culture space. We would like to know your thoughts.EDITORIALPropelling Cell Culture with Automation and 3DCopyright © 2023 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com FEBRUARY - 2023, Vol 03, Issue - 35 (ISSN 2831-8331) Published by ValleyMedia, Inc.To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com Editorial StaffAaron PierceCarolynn WaltersShirley FaithRussell ThomasVisualizersDavid FincherDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsVictor Cruz Clara Matthew
< Page 5 | Page 7 >